« Previous
Next »
Titles
- U.S. Department of Health and Human services overdose prevention strategy1
- U.S. national and state estimates of children living with parents using substances, 2015– 20191
- UPICs hold promise to enhance program integrity across Medicare and Medicaid, but challenges remain1
- USAID: Management improvements needed to better meet global health mission : report to the Chairman, Committee on Foreign Relations, U.S. Senate1
- Unaccompanied alien children program care provider facilities do not include all required security measures in their checklists1
- Uncomplicated urinary tract infections: developing drugs for treatment1
- Understanding coverage considerations for COVID-19 vaccines and treatments2
- Understanding how components of an intervention can influence outcomes1
- Understanding substance use coercion as a barrier to economic stability for survivors of intimate partner violence: policy implications1
- Understanding substance use disorder (SUD) treatment needs using assessment data: final report1
- Understanding the characteristics of older adults in different residential settings: data sources and trends1
- Understanding the impacts of OS-PCORTF projects on data capacity: an interim qualitative assessment1
- Underwriting in the non-group health insurance market: the fundamentals1
- Unique Device Identification System: form and content of the unique device identifier (UDI) : guidance for industry and Food and Drug Administration staff1
- Unique device identification: Policy regarding compliance dates for class I and unclassified devices, direct marking, and Global Unique Device Identification Database requirements for certain devices : guidance for industry and Food and Drug Administration staff1
- Unique device identification: convenience kits : guidance for industry and Food and Drug Administration staff1
- Unique device identification: direct marking of devices : guidance for Industry and Food and Drug administration staff1
- Unique device identification: policy regarding compliance dates for class I and unclassified devices : immediately in effect guidance for industry and Food and Drug Administration staff1
- Unique device identification: policy regarding compliance dates for class I and unclassified devices and certain devices requiring direct marking : immediately in effect guidance for industry and Food and Drug Administration staff1
- Unwanted sexual behavior: improved guidance, access to care, and training needed to better address victims’ behavioral health needs : report to congressional requesters1